NEVVI Medicare utilization intelligence

← back

Provider profile

MACEWAN, IAIN M.D.

Radiation Oncology · NPI 1326300401 · SAN DIEGO, CA

1
Groups
19
Codes · 2024
4,833
Disclosed services

MACEWAN, IAIN is a Radiation Oncology in SAN DIEGO, CA, a member of 1 medical group, who billed 19 distinct codes to Medicare Part B in 2024.

Groups: PROTON DOCTORS PROFESSIONAL CORPORATION (SAN DIEGO, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

4,833
disclosed services
19
codes billed to Medicare Part B
Prior year · CY2023 4,871 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
77525 Complex proton beam radiation treatment premiumpremium premiumpremium
77014 Ct guidance for insertion of radiation therapy fields premiumpremium premiumpremium
G6002 Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy premiumpremium premiumpremium
77523 Intermediate proton beam radiation treatment premiumpremium premiumpremium
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml premiumpremium premiumpremium
77300 Calculation of radiation therapy dose premiumpremium premiumpremium
77336 Continuing radiation therapy consultation per week premiumpremium premiumpremium
77427 Radiation treatment management, 5 treatment sessions premiumpremium premiumpremium
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more premiumpremium premiumpremium
77301 High precision radiation therapy planning premiumpremium premiumpremium
77334 Design and construction of complex radiation treatment device premiumpremium premiumpremium
77263 Complex radiation therapy planning premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
77470 Special radiation treatment premiumpremium premiumpremium
78815 Nuclear medicine study from skull base to mid-thigh with ct scan premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries premiumpremium premiumpremium
77293 Obtaining respiratory data needed to develop the optimal radiation treatment premiumpremium premiumpremium
72197 Mri scan of pelvis before and after contrast premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.